U.S. Markets closed

Can Hypermarcas (HYPMY) Continue to Surge?

Zacks Equity Research

One company that should be on your radar is Hypermarcas S.A. (HYPMY). The stock of this Brazil based developer and manufacturer of drug, health, beauty and personal care products has seen its Zacks Rank surge over the past four weeks, moving from Sell territory to its current position as a Buy.

A key reason for this move has been the positive trend in the earnings estimate revisions picture. For HYPMY’s full year estimate, we have seen 1 estimate go higher in the past 30 days, compared to no estimate moving lower. This trend has helped the consensus estimate to trend higher, going from 20 cents a share a month ago to its current level at 33 cents.

This positive shift in estimates has made some investors take notice and buy the stock. In fact, HYPMY has seen some pretty solid trading lately, as the company has moved higher by 10.6% in the past month.

If Hypermarcas can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put HYPMY on your watch list for the future.

Other top-ranked stocks worth considering in this space include Spectrum Brands Holdings, Inc. (SPB), Central Garden & Pet Company (CENT) and Summer Infant, Inc. (SUMR). Among these, Central Garden & Pet Company carries a Zacks Rank #1 (Strong Buy) and Spectrum and Summer Infant carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

HYPERMARCAS ADR (HYPMY): Free Stock Analysis Report

CENTRAL GARDEN & PET COMPANY (CENT): Free Stock Analysis Report


SUMMER INFANT INC (SUMR): Free Stock Analysis Report

Zacks Investment Research